Pharvaris N.V.
PHVS
$35.14
$1.103.23%
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | 51.26M | 50.40M | 50.40M | 52.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 192.00M | 184.65M | 184.65M | 179.95M |
| Operating Income | -- | -192.00M | -184.65M | -184.65M | -179.95M |
| Income Before Tax | -- | -195.94M | -179.20M | -179.20M | -181.17M |
| Income Tax Expenses | -- | 2.27M | 1.66M | 1.66M | 2.12M |
| Earnings from Continuing Operations | -- | -198.21 | -180.86 | -180.86 | -183.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -198.21M | -180.86M | -180.86M | -183.29M |
| EBIT | -- | -192.00M | -184.65M | -184.65M | -179.95M |
| EBITDA | -- | -191.65M | -184.46M | -184.32M | -179.63M |
| EPS Basic | -- | -3.37 | -3.22 | -3.22 | -3.37 |
| Normalized Basic EPS | -- | -2.08 | -1.99 | -1.99 | -2.08 |
| EPS Diluted | -- | -3.37 | -3.22 | -3.22 | -3.37 |
| Normalized Diluted EPS | -- | -2.08 | -1.99 | -1.99 | -2.08 |
| Average Basic Shares Outstanding | -- | 236.55M | 225.75M | 225.75M | 217.57M |
| Average Diluted Shares Outstanding | -- | 236.55M | 225.75M | 225.75M | 217.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |